SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-16-159830
Filing Date
2016-11-30
Accepted
2016-11-30 19:52:19
Documents
1
Period of Report
2016-11-29

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 4688
  Complete submission text file 0001104659-16-159830.txt   6176
Mailing Address ONE MAIN STREET SUITE 800 CAMBRIDGE MA 02142
Business Address ONE MAIN STREET SUITE 800 CAMBRIDGE MA 02142 (617) 500-7867
Aegerion Pharmaceuticals, Inc. (Issuer) CIK: 0001338042 (see all company filings)

IRS No.: 202960116 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O AEGERION PHARMACEUTICALS INC. ONE MAIN ST., SUITE 800 CAMBRIDGE MA 02142
Business Address
Chan Barbara Y (Reporting) CIK: 0001676343 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34921 | Film No.: 162026514